X Bioscience Public Company Limited (XBIO)

Overview

Xenetic Biosciences, Inc. is a pioneering biopharmaceutical company deeply immersed in the discovery, research, and development of innovative biologic drugs and oncology therapeutics. At the heart of its mission is the advancement of XCART, a state-of-the-art personalized chimeric antigen receptor T cell (CAR T) platform technology. This groundbreaking technology is specifically engineered to target patient-specific tumor neoantigens, offering a highly personalized approach to cancer treatment. Positioned at the forefront of cell-based therapeutics, Xenetic Biosciences focuses on targeting the B-cell receptor present on the surface of an individual patient’s malignant tumor cells. This strategic concentration seeks to revolutionize the treatment of B-cell lymphomas. Headquartered in Framingham, Massachusetts, Xenetic Biosciences leverages its proprietary PolyXen drug delivery platform to form strategic partnerships with key players in the biotechnology and pharmaceutical sectors. Collaborative agreements with industry giants such as Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC, empower Xenetic to broaden its impact and extend its reach in the fight against cancer.

Products and Services

• XCART Platform Technology:

  A cutting-edge personalized CAR T platform technology devised to target patient-specific tumor neoantigens. This innovation is aimed at offering a highly personalized treatment regimen by engineering T cells to specifically target the unique characteristics of a patient’s tumor, particularly for the treatment of B-cell lymphomas.

• Cell-Based Therapeutics:

  Focusing on the advancement of treatments targeting the B-cell receptor on the surface of individual patient's malignant tumor cells. Xenetic Biosciences’ commitment to this area signifies a promising avenue for the treatment of B-cell lymphomas, emphasizing a personalized approach to oncology therapeutics.

• PolyXen Drug Delivery Platform:

  Xenetic Biosciences’ proprietary drug delivery technology, designed to enhance the bio-availability, safety, and efficacy of biologic drugs. The PolyXen platform is utilized in partnership with leading biotechnology and pharmaceutical companies to optimize the therapeutic delivery of biologic agents.